Grace Capital’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-46,983
Closed -$2.35M 88
2017
Q3
$2.35M Sell
46,983
-6,880
-13% -$351K 0.85% 48
2017
Q2
$2.85M Buy
53,863
+580
+1% +$31.1K 1.14% 40
2017
Q1
$2.96M Sell
53,283
-1,015
-2% -$56K 1.22% 40
2016
Q4
$2.83M Sell
54,298
-500
-0.9% -$24.1K 1.28% 38
2016
Q3
$2.65M Buy
54,798
+3,190
+6% +$161K 1.16% 46
2016
Q2
$2.86M Sell
51,608
-41
-0.1% -$2.26K 1.2% 41
2016
Q1
$2.76M Buy
51,649
+6,195
+14% +$305K 1.24% 41
2015
Q4
$2.34M Buy
45,454
+5,085
+13% +$253K 1.1% 48
2015
Q3
$1.91M Hold
40,369
0.79% 61
2015
Q2
$1.91M Buy
+40,369
New +$1.77M 0.79% 61

Other funds holding PBH

Grace Capital's PBH Position: Q4 2017 in Review

Grace Capital sold out of Prestige Consumer Healthcare (PBH) in Q4 2017, closing a stake of 46,983 shares — an estimated $2.35M sold.

Grace Capital first reported a position in PBH in Q2 2015 and held it in 10 quarters. The position peaked at $2.96M in Q1 2017. 251 funds tracked by Wall St. Rank hold PBH as of Q4 2017.

  • Grace Capital reported no remaining Prestige Consumer Healthcare position as of Q4 2017 after selling out during the quarter.
  • Grace Capital sold 46,983 Prestige Consumer Healthcare shares in Q4 2017, an estimated $2.35M.
  • Grace Capital first reported a position in Prestige Consumer Healthcare in Q2 2015 and held it in 10 quarters.
  • Grace Capital's Prestige Consumer Healthcare position peaked at $2.96M in Q1 2017.
  • 251 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2017.

Based on Grace Capital's 13F filing for Q4 2017, filed 12 Feb 2018.